Today: 7 February 2026
Subscribe

Verizon stock today: VZ edges up as DOJ DEI probe headline hangs over telecom ahead of Jan. 30 earnings

Verizon stock today: VZ edges up as DOJ DEI probe headline hangs over telecom ahead of Jan. 30 earnings

NEW YORK, December 30, 2025, 15:17 ET — Regular session Verizon Communications Inc shares were up 0.5% at $40.69 in afternoon trading on Tuesday, bucking a mostly flat U.S. market as investors digested new regulatory scrutiny and looked ahead to the carrier’s next earnings update. Reuters The latest headline matters because legal and compliance risk can move quickly for large government contractors, and telecoms are already grappling with intense competition and heavy capital spending. Any shift in policy pressure can influence costs, disclosures and management attention. Reuters It also lands during year-end, low-liquidity trading, when relatively small flows can push
30 December 2025
·
TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

NEW YORK, December 30, 2025, 15:14 ET — Regular session Shares of TIC Solutions, Inc. (TIC) fell about 3.5% to $10.02 in afternoon trading on Tuesday, underperforming a largely steady U.S. equity market. The stock last closed at $10.38. The decline came in holiday-thin trade as investors recalibrated rate expectations after the Federal Reserve’s December-meeting minutes hit the tape. “At the end of the day, solid corporate profits can make up for a lot of sins,” said Ryan Detrick, chief market strategist at Carson Group. Reuters The slide matters for TIC because investors have been focused on execution rather than
30 December 2025
··
Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

NEW YORK, December 30, 2025, 15:20 ET — Regular session Applied Materials, Inc. (AMAT.O) shares slipped on Tuesday, with investors weighing fresh signs of tougher competition in China for semiconductor equipment makers. The stock was down 1.1% at $260.27 in mid-afternoon New York trade. The stock drew attention after Reuters reported China is requiring chipmakers seeking approval to build or expand fabs to use at least 50% domestically made equipment when adding new capacity. The measure is not publicly documented and is enforced through procurement tenders, people familiar with the matter told Reuters, and authorities can relax the threshold where
30 December 2025
·····
Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

NEW YORK, December 30, 2025, 15:16 ET — Regular session Travere Therapeutics Inc shares were down about 3.8% at $37.39 on Tuesday afternoon, extending losses after recent insider-trading disclosures. The stock traded between $37.27 and $39.20, with about 893,000 shares changing hands. (TVTX quote) The selling matters because it lands just weeks before a major regulatory milestone for the rare-disease drugmaker. Traders often react to clusters of insider sales — even when they are planned — as they reassess near-term positioning. Travere, based in San Diego, markets Filspari for a kidney disease called IgA nephropathy, and is seeking an expansion
30 December 2025
Qualcomm stock edges up as Fed minutes hit; QCOM eyes Feb. 4 earnings call

Qualcomm stock edges up as Fed minutes hit; QCOM eyes Feb. 4 earnings call

NEW YORK, December 30, 2025, 15:14 ET — Regular session Qualcomm (QCOM.O) shares were up about 0.2% at $173.75 in afternoon trading on Tuesday, hovering near Monday’s close as markets digested new details on the U.S. interest-rate outlook. That matters for Qualcomm and other semiconductor names because investors often value them like “growth” stocks, whose prices can swing when bond yields move. In year-end trading, the rate narrative can outweigh company-specific headlines. Minutes from the Federal Reserve’s Dec. 9-10 meeting — the detailed account of policymakers’ debate — showed officials split even after approving a quarter-point, or 0.25 percentage point,
30 December 2025
····
Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

NEW YORK, December 30, 2025, 2:30 PM ET — Regular session Shares of Catalyst Pharmaceuticals, Inc. fell 3.0% to $23.33 in afternoon trading on Tuesday. The stock has traded between $23.30 and $24.10 so far in the session. The drop matters because trading can get choppy in the final days of the year, when fewer investors are active and price moves can be exaggerated. Mid-cap healthcare names often swing more than the major indexes in that setting. Catalyst fell 1.2% on Monday to close at $24.06, according to MarketWatch data, and it remains well below its June 9 52-week high
30 December 2025
··
Seagate stock edges lower as year-end AI trade cools; STX turns to January earnings

Seagate stock edges lower as year-end AI trade cools; STX turns to January earnings

NEW YORK, December 30, 2025, 15:01 ET — Regular session Seagate Technology Holdings plc shares were down 0.2% at $280.77 in afternoon trading on Tuesday, drifting after a year when the hard-drive maker became a marquee bet on AI-linked data-center spending. The stock has traded between $280.19 and $284.09 so far in the session, with about 694,000 shares changing hands. The soft patch matters because Seagate has been one of 2025’s standout infrastructure winners, leaving the stock more sensitive to shifts in sentiment around cloud budgets, storage pricing and the durability of the AI spending cycle. Investors are also closing
30 December 2025
··
Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

NEW YORK, December 30, 2025, 14:30 ET — Regular session Shares of Kymera Therapeutics fell about 3% to $77.94 in afternoon trading on Tuesday, lagging a broader biotech dip. The SPDR S&P Biotech ETF was down about 1.4%, while the iShares Nasdaq Biotechnology ETF slipped about 1.1%. The pullback matters because Kymera has been one of the sector’s higher-volatility names this month, after a surge tied to new clinical data and a subsequent stock sale that increased its share count. With most of its next major readouts still far off, investors have been quick to reprice the stock around financing
30 December 2025
··
Nebius stock slips today after CEO files to sell shares — what traders are watching next

Nebius stock slips today after CEO files to sell shares — what traders are watching next

NEW YORK, December 30, 2025, 15:09 ET — Regular session Nebius Group N.V. shares slipped on Tuesday after a regulatory filing showed chief executive Arkady Volozh plans to sell a small block of stock around year-end. SEC+1 The disclosure matters because Nebius has become a closely watched AI infrastructure name, where investors have been quick to react to any potential increase in share supply. Year-end trading can amplify moves, as fewer shares changing hands can push prices around. SEC Form 144 is the SEC notice insiders file when they intend to sell “control” securities, typically ahead of the actual transactions.
30 December 2025
·
Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

NEW YORK, December 30, 2025, 3:07 PM ET — Regular session Shares of Almonty Industries Inc fell about 3.9% to $8.90 in afternoon trading on Tuesday after giving up an early rise, with the stock swinging between $8.90 and $9.39. The pullback comes as investors focus on tungsten, a hard metal used in munitions, industrial tooling and electronics, at a moment when governments are pushing to secure strategic supply chains. A CBS News report published on Monday said Chief Executive Lewis Black met U.S. officials, including at the White House, before touring Almonty’s Sangdong mine in South Korea and signing
30 December 2025
···
SoFi stock today: SOFI barely moves after Fed minutes; what investors watch next

SoFi stock today: SOFI barely moves after Fed minutes; what investors watch next

NEW YORK, December 30, 2025, 3:01 PM ET — Regular session SoFi Technologies, Inc. shares were down 0.1% at $26.80 on Tuesday afternoon, after trading between $26.65 and $27.14. The Federal Reserve released minutes from its Dec. 9–10 meeting at 2:00 p.m. ET, putting fresh attention on how quickly policymakers might cut interest rates again. Federal Reserve That matters for SoFi because investors tend to treat the fintech lender as sensitive to shifts in borrowing costs, which can influence consumer demand for loans and a lender’s funding expenses. Trading across Wall Street was choppy in a holiday-shortened week, with investors
30 December 2025
··
Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

NEW YORK, December 30, 2025, 14:54 ET — Regular session Shares of Praxis Precision Medicines Inc (NASDAQ: PRAX) slipped about 3% on Tuesday, giving back part of a sharp rally sparked by an FDA regulatory boost for its lead essential tremor program. The stock was down 3% at $295.50 as of 2:39 p.m. ET, after opening at $304.00 and trading between $286.58 and $304.70. The company said on Monday the U.S. Food and Drug Administration granted Breakthrough Therapy Designation for ulixacaltamide to treat essential tremor, and said the decision was based on positive topline results from the Essential3 program, two
30 December 2025
··
Why Western Digital stock is down today: WDC slides as year-end rotation cools AI-hardware trades

Why Western Digital stock is down today: WDC slides as year-end rotation cools AI-hardware trades

NEW YORK, December 30, 2025, 3:00 PM ET — Regular session Western Digital Corp shares fell 1.7% to $176.55 on Tuesday, after opening higher and sliding through the afternoon. The stock touched $181.34 earlier in the session before dipping as low as $176.31. The pullback lands after a standout year for the data-storage maker, whose shares have surged about 303% in 2025, making it one of the S&P 500’s biggest gainers. That steep run has made the stock a frequent target for late-December portfolio reshuffling. Barron’s Broader U.S. indexes were little changed in choppy, light-volume trading, with investors repositioning inside
30 December 2025
···
Carvana stock drifts in thin trade after Fed minutes — what CVNA investors are watching

Carvana stock drifts in thin trade after Fed minutes — what CVNA investors are watching

NEW YORK, December 30, 2025, 14:52 ET — Regular session Carvana Co shares edged lower on Tuesday afternoon, trading down less than 0.1% at $433.32, as year-end portfolio shifts kept risk appetite uneven across consumer names. The muted move matters because Carvana has become a high-beta momentum stock after a sharp turnaround, and thin holiday volumes can exaggerate day-to-day swings even when headlines are light. Investors also had fresh Federal Reserve minutes to digest. Rate expectations matter for used-car demand because financing costs influence monthly payments, a key factor for many buyers. Broader U.S. markets were subdued in choppy trading,
30 December 2025
····
Why Caris Life Sciences (CAI) stock is down today as biotech slips

Why Caris Life Sciences (CAI) stock is down today as biotech slips

NEW YORK, December 30, 2025, 14:58 ET — Regular session Caris Life Sciences shares were down about 1.8% at $27.44 as of 2:41 p.m. ET, after trading between $27.00 and $27.97 during Tuesday’s session. The drop came as biotech stocks underperformed, with the SPDR S&P Biotech ETF down about 1.5% and the iShares Nasdaq Biotechnology ETF off about 1.2%. The S&P 500 was little changed and the Nasdaq was flat, Reuters data showed. Reuters That matters for Caris because the newly public cancer diagnostics company tends to move with shifts in risk appetite for healthcare growth names, even when there
30 December 2025
Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up

Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up

NEW YORK, December 30, 2025, 14:50 ET — Regular session Shares of lululemon athletica inc. fell about 0.6% to $211.30 in afternoon trading on Tuesday after founder Chip Wilson launched a proxy fight — a campaign to win shareholder votes for board seats — seeking to reshape the board. The stock had gained about 2% on Monday, Reuters reported. Reuters The board fight comes as the athletic apparel maker searches for a permanent chief executive after Calvin McDonald said he would step down on Jan. 31. Chief financial officer Meghan Frank and chief commercial officer André Maestrini are set to
30 December 2025
·
Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

NEW YORK, December 30, 2025, 14:40 ET — Regular session Shares of Cogent Biosciences, Inc. fell 2.7% to $36.88 on Tuesday after the biotech said it submitted a New Drug Application to the U.S. Food and Drug Administration for its drug candidate bezuclastinib in nonadvanced systemic mastocytosis. Yahoo Finance An NDA is the formal request asking the FDA to review a drug for marketing approval, a key inflection point for development-stage biotechs with no products on the market. U.S. Food and Drug Administration Systemic mastocytosis is a rare disorder marked by abnormal accumulation and activation of mast cells — immune
30 December 2025
··
Amgen stock dips as Lumakras combo trial ends; MariTide data now the next watch

Amgen stock dips as Lumakras combo trial ends; MariTide data now the next watch

NEW YORK, December 30, 2025, 2:56 PM ET — Regular session Amgen Inc. shares were down 0.4% at $328.32 at 2:56 p.m. ET on Tuesday, after trading between $325.90 and $330.18. The modest move matters because investors are grading Amgen’s pipeline for new growth while several mature products face price pressure and biosimilar competition. Oncology and obesity remain two key swing factors for the stock heading into 2026. Biotech stocks lagged, with the iShares Nasdaq Biotechnology ETF down about 1.1%, while the healthcare sector ETF was roughly flat and the S&P 500 ETF hovered near unchanged. Verastem Oncology said it
30 December 2025
··
Texas Instruments stock today: TXN flat after ReRAM licensing deal as Fed minutes land

Texas Instruments stock today: TXN flat after ReRAM licensing deal as Fed minutes land

NEW YORK, December 30, 2025, 14:44 ET — Regular session Texas Instruments Incorporated (TXN) shares were little changed on Tuesday after memory developer Weebit Nano said it had licensed its resistive random access memory, or ReRAM, technology to the chipmaker. The stock was down about 0.01% at $175.67 in afternoon trade, and TI executive Amichai Ron said the partnership would give customers access to “industry-leading NVM technology.” Weebit The announcement matters because embedded non-volatile memory — storage that keeps data when power is off — is a key building block for chips that run cars, factory equipment and other electronics
30 December 2025
··
Mastercard stock dips in thin year-end trade as Fed minutes sharpen rate focus

Mastercard stock dips in thin year-end trade as Fed minutes sharpen rate focus

NEW YORK, December 30, 2025, 14:45 ET — Regular session Mastercard Incorporated shares were down 0.3% at $576.37 in afternoon trading on Tuesday, after moving between $574.55 and $579.49 earlier in the session. Volume was about 683,000 shares. The small move still matters into year-end because investors use card networks as a bellwether for consumer spending. Mastercard earns fees when transactions run across its network, so shifts in shopping and travel can show up quickly in volume trends. Rates are also front and center for the group. Payment processors trade like high-quality growth stocks inside financials, which can make them
30 December 2025
···
1 … 652 653 654 655 656 … 1,631

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop